{"uri":"genotypic-hiv-coreceptor-tropism-assay-jmnck5e","version_id":"0","protocol_name":"Genotypic HIV coreceptor tropism assay","protocol_name_html":"Genotypic HIV coreceptor tropism assay","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1521526261","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0187393","fork_id":"","public_fork_note":"","number_of_steps":"5","has_versions":"1","first_published_date":"1504103374","publish_date":"2017-08-30 14:29:34","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>The assay is intended to amplify and sequence the HIV-1 gp120 V3 domain and infer if the virus can use the CXCR4 coreceptor for cell entry. The use of this coreceptor renders the virus not susceptible to the CCR5 coreceptor antagonist maraviroc.\u00a0<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"7566","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1504082899","protocol_affiliation":"University of Siena, Italy","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.jmnck5e","doi_status":"2","changed_fork_steps":null,"profile_url":"x223a403v2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/015.png","full_name":"Maurizio Zazzi","created_by":"Maurizio Zazzi","private_link":"B77D32E90ACD4940CD43F7744599C2B6","original_img":"1","username":"maurizio-zazzi","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0187393","manuscript_citation":"Rossetti B,  Gagliardini R,  Meini G,  Sterrantino G,  Colangeli V,  Re MC,  Latini A,  Colafigli M,  Vignale F,  Rusconi S,  Micheli V,  Biagio AD,  Orofino G,  Ghisetti V,  Fantauzzi A,  Vullo V,  Grima P,  Francisci D,  Mastroianni C,  Antinori A,  Trezzi M,  Lisi L,  Navarra P,  Canovari B,  Monforte AD,  Lamonica S,  D\u2019Avino A,  Zazzi M,  Giambenedetto SD,  Luca AD,   , Switch to maraviroc with darunavir\/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. PLoS ONE  12(11). doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0187393\">10.1371\/journal.pone.0187393<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":261334,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"HIV, genotype, coreceptor","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"1","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Maurizio Zazzi","authors_list":[{"name":"Maurizio Zazzi","affiliation":"University of Siena, Italy","username":"maurizio-zazzi","profile_image":"\/img\/avatars\/015.png"}],"user":{"profile_image":"\/img\/avatars\/015.png","username":"maurizio-zazzi","full_name":"Maurizio Zazzi","created_by":"Maurizio Zazzi"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"584934","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"1887D246611842058BD5FE83031FBD73","previous_guid":null,"previous_id":"0","last_modified":"1504083959","components":[{"component_id":"998322","previous_id":0,"original_id":"0","guid":"37F524C37FCE4FB595548D2CEF1C7D1F","previous_guid":null,"component_type_id":"6","data_id":"0","data":"","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0},{"component_id":"998321","previous_id":"998322","original_id":"0","guid":"31A317769FF74162A7290F76AEE76CAF","previous_guid":"37F524C37FCE4FB595548D2CEF1C7D1F","component_type_id":"1","data_id":null,"data":"<p>Depending on which kind of sample you have to analyze, extract DNA from whole blood by using the\u00a0High Pure Viral Nucleic Acid Kit (Roche Applied Science, catalogue number 11858874001) OR extract RNA from plasma by using the\u00a0QIAamp Viral RNA Mini Kit (Qiagen, catalogue number\u00a052904).<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Depending on which kind of sample you have to analyze, extract DNA from whole blood by using the\u00a0High Pure Viral Nucleic Acid Kit (Roche Applied Science, catalogue number 11858874001) OR extract RNA from plasma by using the\u00a0QIAamp Viral RNA Mini Kit (Qiagen, catalogue number\u00a052904).<\/p>"},"is_project":0}]},{"id":"584935","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"2C0F08EC556F48C892510FD4D0E395DE","previous_guid":"1887D246611842058BD5FE83031FBD73","previous_id":"584934","last_modified":"1504090997","components":[{"component_id":"998323","previous_id":0,"original_id":"0","guid":"9C5978DD17384B6DBBEA2DCDB461E4B9","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Amplify the HIV-1 gp120 V3 coding region by the following RT-nested PCR protocol:<\/p>\n<p>\u00a0<\/p>\n<p><strong>RT (when starting from plasma RNA)<\/strong><\/p>\n<p>The reaction mix contains 20\u00a0\u03bcL RNA extract pre-heated at 70\u00b0C for 5 min, 6 \u03bcL Improm II 5x Reaction buffer (Promega), 4\u00a0\u03bcL 1.25 mM each dNTP, \u00a01.8\u00a0\u03bcL MgCl<sub>2<\/sub>, 1\u00a0\u03bcL 50 ng\/\u03bcL random Hexanucleotides (Promega), 0.5\u00a0\u03bcL RNasin RNase inhibitor and 1\u00a0\u03bcL Improm II Reverse Transcriptase (Promega). Run at 37\u00b0C for 45 min, 80\u00b0C for 5 min, hold at 4\u00b0C.<\/p>\n<p>\u00a0<\/p>\n<p><strong>First PCR<\/strong><\/p>\n<p>The reaction mix contains 5\u00a0\u03bcL RT reaction mixture (when starting from plasma RNA) or 2-5 \u03bcL DNA extract (when starting from whole blood), 28 \u00b5L distilled water, 10 \u00b5L 5X Colorless GoTaq Flexi Buffer, 3.2 1.25 mM each dNTP, 0.2 \u00b5L 5U\/\u00b5L GoTaq Hot Start Polymerase (Promega), 5 \u00b5L 25 mM MgCl<sub>2<\/sub>, 0.6 \u00b5L 10 pmol\/UL each primer P150 (5'-AATGTCAGCACAGTACAATGYACACAT-3', coordinates 6945-6971 in\u00a0the reference HXB2 genome) and P151 (5'-CTACTTTATATTTATATAATTCAYTTCTC-3', 7661-7689) . Run 25 cycles at 49\u00b0C for 30 sec, 72\u00b0C for 50 sec, 93\u00b0C for 30 sec, followed by a final extension at 50\u00b0C for 1 min and 72\u00b0C for 10 min.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Second PCR<\/strong><\/p>\n<p>The reaction mix contains 1 \u03bcL of the first PCR mixture, 18 \u00b5L distilled water, 6 \u00b5L 5X Colorless GoTaq Flexi Buffer, 0.8 1.25 mM each dNTP, 0.2 \u00b5L 5U\/\u00b5L GoTaq Hot Start Polymerase (Promega), 3 \u00b5L 25 mM MgCl<sub>2<\/sub>, 0.3 \u00b5L 10 pmol\/UL each primer P537 (5'-CAGTACARTGYACACATGGAAT-3',\u00a0coordinates 6955\u20136976\u00a0in\u00a0the reference HXB2 genome) and\u00a0P538 (5'-TAGAAAAATTCYCCTCYACAATTAAA-3', 7353\u20137373) . Run 25 cycles at 49\u00b0C for 30 sec, 72\u00b0C for 50 sec, 93\u00b0C for 30 sec, followed by a final extension at 50\u00b0C for 1 min and 72\u00b0C for 10 min.<\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Amplify the HIV-1 gp120 V3 coding region by the following RT-nested PCR protocol:<\/p>\n<p>\u00a0<\/p>\n<p><strong>RT (when starting from plasma RNA)<\/strong><\/p>\n<p>The reaction mix contains 20\u00a0\u03bcL RNA extract pre-heated at 70\u00b0C for 5 min, 6 \u03bcL Improm II 5x Reaction buffer (Promega), 4\u00a0\u03bcL 1.25 mM each dNTP, \u00a01.8\u00a0\u03bcL MgCl<sub>2<\/sub>, 1\u00a0\u03bcL 50 ng\/\u03bcL random Hexanucleotides (Promega), 0.5\u00a0\u03bcL RNasin RNase inhibitor and 1\u00a0\u03bcL Improm II Reverse Transcriptase (Promega). Run at 37\u00b0C for 45 min, 80\u00b0C for 5 min, hold at 4\u00b0C.<\/p>\n<p>\u00a0<\/p>\n<p><strong>First PCR<\/strong><\/p>\n<p>The reaction mix contains 5\u00a0\u03bcL RT reaction mixture (when starting from plasma RNA) or 2-5 \u03bcL DNA extract (when starting from whole blood), 28 \u00b5L distilled water, 10 \u00b5L 5X Colorless GoTaq Flexi Buffer, 3.2 1.25 mM each dNTP, 0.2 \u00b5L 5U\/\u00b5L GoTaq Hot Start Polymerase (Promega), 5 \u00b5L 25 mM MgCl<sub>2<\/sub>, 0.6 \u00b5L 10 pmol\/UL each primer P150 (5'-AATGTCAGCACAGTACAATGYACACAT-3', coordinates 6945-6971 in\u00a0the reference HXB2 genome) and P151 (5'-CTACTTTATATTTATATAATTCAYTTCTC-3', 7661-7689) . Run 25 cycles at 49\u00b0C for 30 sec, 72\u00b0C for 50 sec, 93\u00b0C for 30 sec, followed by a final extension at 50\u00b0C for 1 min and 72\u00b0C for 10 min.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Second PCR<\/strong><\/p>\n<p>The reaction mix contains 1 \u03bcL of the first PCR mixture, 18 \u00b5L distilled water, 6 \u00b5L 5X Colorless GoTaq Flexi Buffer, 0.8 1.25 mM each dNTP, 0.2 \u00b5L 5U\/\u00b5L GoTaq Hot Start Polymerase (Promega), 3 \u00b5L 25 mM MgCl<sub>2<\/sub>, 0.3 \u00b5L 10 pmol\/UL each primer P537 (5'-CAGTACARTGYACACATGGAAT-3',\u00a0coordinates 6955\u20136976\u00a0in\u00a0the reference HXB2 genome) and\u00a0P538 (5'-TAGAAAAATTCYCCTCYACAATTAAA-3', 7353\u20137373) . Run 25 cycles at 49\u00b0C for 30 sec, 72\u00b0C for 50 sec, 93\u00b0C for 30 sec, followed by a final extension at 50\u00b0C for 1 min and 72\u00b0C for 10 min.<\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"998324","previous_id":"998323","original_id":"0","guid":"3EBC029D51BE4C4C89B0FF95E516AF9C","previous_guid":"9C5978DD17384B6DBBEA2DCDB461E4B9","component_type_id":"6","data_id":"0","data":"","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0}]},{"id":"584963","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"890A19E1493B41C5AB9363CF6FACB8B4","previous_guid":"2C0F08EC556F48C892510FD4D0E395DE","previous_id":"584935","last_modified":"1504101159","components":[{"component_id":"998397","previous_id":0,"original_id":"0","guid":"3AF61B1ECE4244FFA8E8F0E295986CC7","previous_guid":null,"component_type_id":"6","data_id":"0","data":"","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0},{"component_id":"998396","previous_id":"998397","original_id":"0","guid":"CE60C0FAECDE44A78EBF98F70CE03EEA","previous_guid":"3AF61B1ECE4244FFA8E8F0E295986CC7","component_type_id":"1","data_id":null,"data":"<p><strong>Visualization of the amplified product<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Load 5 \u00b5L of the second PCR mixture on a 1.5% standard agarose gel, run elecrophoresis at 5-10 V\/cm for 20-40 min and stain with ethidium bromide or equivalent DNA stain. Estimate visually\u00a0\u00a0the expected 421-bp band since the product concentration dictates the dilution factor for the following step.<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>Visualization of the amplified product<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Load 5 \u00b5L of the second PCR mixture on a 1.5% standard agarose gel, run elecrophoresis at 5-10 V\/cm for 20-40 min and stain with ethidium bromide or equivalent DNA stain. Estimate visually\u00a0\u00a0the expected 421-bp band since the product concentration dictates the dilution factor for the following step.<\/p>"},"is_project":0}]},{"id":"584964","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"345668BB51B54A78AD8644C4B7329473","previous_guid":"890A19E1493B41C5AB9363CF6FACB8B4","previous_id":"584963","last_modified":"1504102818","components":[{"component_id":"998399","previous_id":0,"original_id":"0","guid":"B44B8A3B1C55419B89C7F148E9095DA0","previous_guid":null,"component_type_id":"6","data_id":"0","data":"","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0},{"component_id":"998398","previous_id":"998399","original_id":"0","guid":"3D4C2CA34E0A4EE2B6DD05A00070E503","previous_guid":"B44B8A3B1C55419B89C7F148E9095DA0","component_type_id":"1","data_id":null,"data":"<p><strong>Sequencing reaction<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Dilute the PCR product down to 1-2 ng\/\u00b5L. If the nested PCR ran as expected a 1\/50 to 1\/200 dilution factor should apply. Note that when the dilution factor is higher than 20 you do not need to purify the PCR product before the sequencing reaction because the nested PCR step used low amounts of both primers and dNTPs and residual amounts following such dilution will not interfere with the sequencing step. If necessary, purify the PCR product with your system of choice.<\/p>\n<p>\u00a0<\/p>\n<p>Use 3 \u00b5L of diluted\/purified PCR product as the template for a cycle sequencing reaction with BigDye 1.1 or BigDye 3.1 or equivalent. Run the reaction for 25 cycles made of\u00a096\u00b0C for 10 sec,\u00a050\u00b0C for 5 sec,\u00a060\u00b0C for 2 min. Setup two identical reactions, one driven by primer P537 and one driven by primer P538.<\/p>\n<p>\u00a0<\/p>\n<p>AT the end of the sequencing reaction, purify the reactions from unincorporated labelled ddNTPs with your system of choice. We recommend the BigDye X-terminator system from Applied Biosystems because of its ease of use and\u00a0complete preservation of the sequencing products. Once the purification step has been completed,\u00a0load the reactions on the capillary elctrophoresis apparatus of your choice and run the migration as per instrument instructions.\u00a0<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>Sequencing reaction<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Dilute the PCR product down to 1-2 ng\/\u00b5L. If the nested PCR ran as expected a 1\/50 to 1\/200 dilution factor should apply. Note that when the dilution factor is higher than 20 you do not need to purify the PCR product before the sequencing reaction because the nested PCR step used low amounts of both primers and dNTPs and residual amounts following such dilution will not interfere with the sequencing step. If necessary, purify the PCR product with your system of choice.<\/p>\n<p>\u00a0<\/p>\n<p>Use 3 \u00b5L of diluted\/purified PCR product as the template for a cycle sequencing reaction with BigDye 1.1 or BigDye 3.1 or equivalent. Run the reaction for 25 cycles made of\u00a096\u00b0C for 10 sec,\u00a050\u00b0C for 5 sec,\u00a060\u00b0C for 2 min. Setup two identical reactions, one driven by primer P537 and one driven by primer P538.<\/p>\n<p>\u00a0<\/p>\n<p>AT the end of the sequencing reaction, purify the reactions from unincorporated labelled ddNTPs with your system of choice. We recommend the BigDye X-terminator system from Applied Biosystems because of its ease of use and\u00a0complete preservation of the sequencing products. Once the purification step has been completed,\u00a0load the reactions on the capillary elctrophoresis apparatus of your choice and run the migration as per instrument instructions.\u00a0<\/p>"},"is_project":0}]},{"id":"584965","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"BED2B854078B43B7ACA7FEAF5A8E646A","previous_guid":"345668BB51B54A78AD8644C4B7329473","previous_id":"584964","last_modified":"1504103044","components":[{"component_id":"998401","previous_id":0,"original_id":"0","guid":"5998578224F740A08EAB68C2EB8A3946","previous_guid":null,"component_type_id":"6","data_id":"0","data":"","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0},{"component_id":"998400","previous_id":"998401","original_id":"0","guid":"63FF7975E3284A51B7FF86097CE0D586","previous_guid":"5998578224F740A08EAB68C2EB8A3946","component_type_id":"1","data_id":null,"data":"<p><strong>Interpretation<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Process the raw sequencing files with the software of your choice, edit the contig to generate a sequence around 370 bp devoid of primer sequences at both ends. Submit the sequence to the <a href=\"http:\/\/coreceptor.bioinf.mpi-inf.mpg.de\/index.php\" target=\"_blank\">geno2pheno<\/a> server\u00a0with the false positive rate threshold of your choice to infer if the sequence obtained is derived from a CCR5 or CXCR4 using virus.<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>Interpretation<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Process the raw sequencing files with the software of your choice, edit the contig to generate a sequence around 370 bp devoid of primer sequences at both ends. Submit the sequence to the <a href=\"http:\/\/coreceptor.bioinf.mpi-inf.mpg.de\/index.php\" target=\"_blank\">geno2pheno<\/a> server\u00a0with the false positive rate threshold of your choice to infer if the sequence obtained is derived from a CCR5 or CXCR4 using virus.<\/p>"},"is_project":0}]}]}